New coil aims to plug brain aneurysms more safely and cheaply
NCT ID NCT05636124
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new coil device (Kaneka i-ED) in 50 people with wide-necked brain aneurysms. The coil is placed inside the aneurysm to block blood flow and prevent rupture. Researchers will check how well it works, how safe it is, and whether it saves money compared to standard treatments over 18 months.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Kaneka i-ED coil (a medical device used to block blood flow into brain aneurysms)
- What this could lead to
- If successful, this coil could offer a safer, more cost-effective way to treat wide-necked brain aneurysms, reducing the need for repeat procedures.
- What could go wrong
- This is a small, early-stage study with only 50 participants and no control group. The device may not work better than existing options, and there are risks of serious complications like bleeding or stroke.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
50 people
The number who actually took part.
- Started
-
Jun 2023
- Expected to finish
-
Jul 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 80 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion criteria: * Patient presenting with ruptured or unruptured cerebral aneurysm appropriate for endovascular treatment as determined by the neuroendovascular treating team * Wide neck side wall or bifurcation intracranial aneurysms (neck \> or = to 4 mm or dome-to-neck ratio \< 2) within the anterior or posterior circulation * The neurointerventionist feels that the aneurysm can be safely treated using endovascular techniques (direct or assisted coiling) * Patients are 18-80 years of age (inclusive) * Patient must be Hunt and Hess grade 0 to 3 * Patient has given fully informed consent to endovascular coiling procedure. If the patient cannot consent for themselves, appropriate written consent has been sought from their next of kin or appropriate power of attorney. * Aneurysm 6-14 mm in diameter * Patient is willing and able to return for clinical evaluation and follow-up imaging evaluation (angiography) at 3-6 months and 12-18 months after endovascular treatment * The patient has not been previously enrolled in this trial or another related ongoing trial * The aneurysm has not been previously treated by coiling or clipping Exclusion criteria: * Patient has more than one aneurysm requiring treatment in the current treatment session, and only one of those to be treated aneurysms fits the Kaneka inclusion criteria (i.e., - if either (1) a patient has multiple aneurysms, but only one will be treated at enrollment; or (2) if two or more aneurysms are treated during the current treatment session and BOTH are able to be enrolled, then they remain eligible for the trial). Non-treated additional aneurysms may be treated at a later date with any coil type that the operator chooses). * Target aneurysm has had previous coil treatment or has been surgically clipped * Hunt and Hess score is 4 or 5 after subarachnoid hemorrhage * Inability to obtain informed consent * Medical or surgical comorbidity such that the patient's life expectancy is less than 2 years
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Intracranial aneurysms are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Baptist Health Jacksonville
Jacksonville, Florida, 32207, United States
-
Icahn School of Medicine at Mount Sinai
New York, New York, 10029, United States
-
Prisma Health
Greenville, South Carolina, 29605, United States
-
Sutter Health
Danville, California, 94526, United States
-
University of South Florida
Tampa, Florida, 33606, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- China builds national watchdog for brain blood vessel devices
- Can a tiny mesh device defuse brain aneurysms? a registry investigates
- Brain aneurysm showdown: which coated stent causes fewer strokes?
- New ultrasound spots metal in brain after aneurysm clipping
- Can a smart app make brain aneurysm Follow-Up better?
- AI to uncover hidden social risks for brain aneurysm patients